Potential new treatment to stop Alzheimer’s disease: Molecular ‘tweezers’ break up toxic aggregations of proteins in mouse model

Using a specific biological compound they call molecular “tweezers,” researchers report that, for the first time in a living mouse model for Alzheimer’s (AD), the compound cleared the existing amyloid ² and Tau aggregates, and proved protective to the neuron’s synapses, another target common to AD.